Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
1-acylglycerol-3-phosphate O-acyltransferase 6 pseudogene (ENSG00000257976) is classified as a pseudogene, meaning it does not encode an active protein and is not a functional enzyme, receptor, or established pharmacological target. The canonical, protein-coding form (AGPAT6/GPAT4) participates in glycerolipid metabolism and lipid biosynthesis[2][3]; however, this pseudogene does not contribute directly to such processes. Summary of key points: - This entry refers to a pseudogene, not a functional protein. - It is not a therapeutic target. - The canonical protein-coding gene (AGPAT6/GPAT4) is involved in lipid metabolism, but the pseudogene is not. - There are no biological functions, disease associations, drugs, or safety concerns relevant to pseudogenes of this class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1-acylglycerol-3-phosphate O-acyltransferase 6 pseudogene.